» Articles » PMID: 35479498

Interoception Dysfunction Contributes to the Negative Emotional Bias in Major Depressive Disorder

Overview
Specialty Psychiatry
Date 2022 Apr 28
PMID 35479498
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous research studies have demonstrated that impaired interoception is involved in emotional information processing in major depressive disorder (MDD). Heartbeat-evoked potential (HEP) amplitudes, an index for interoception, could be manipulated by emotional faces in healthy people. Considering negative emotional bias is the core characteristic in MDD, we hypothesized that interoception dysfunction was associated with the negative emotional bias in MDD.

Methods: An electroencephalogram (EEG) study under an emotional faces task was applied to explore the relationship between interoception and emotional bias. HEPs before emotional faces stimuli were used to predict the late positive potential (LPP) amplitudes and it worked as an index of emotional bias. Twenty-seven patients with MDD and 27 healthy controls (HCs) participated in this study. Source analysis gave an auxiliary description for results in sensory level.

Results: Major depressive disorders (MDDs) had poor performance in the heartbeat count task (HCT) and attenuate HEP average amplitudes (455-550 ms). Compared with HCs, cluster-based permutation -tests revealed that MDDs had attenuated LPP amplitudes (300-1,000 ms) over centroparietal regions and enhanced LPP amplitudes over frontocentral regions. Furthermore, abnormal attenuated HEPs could predict aberrant LPPs under sad face stimuli in MDDs, which could be associated with the dysfunction of the anterior cingulate cortex (ACC) and right insula.

Conclusion: Mediated by ACC and insula, interoception dysfunction contributes to the negative emotional bias of MDD, highlighting the importance of interoception in the disorder.

Citing Articles

Interoception as a key node in the multidimensional psychological structural model of depression: a structural equation model analysis of integrating environmental, cognitive and behavioral-emotional factors.

Liu J, Li J, Wang T, Wu Y, Liu X, Gao X BMC Psychiatry. 2025; 25(1):205.

PMID: 40050850 PMC: 11887121. DOI: 10.1186/s12888-025-06648-z.


Interoception mediates the association between social support and sociability in patients with major depressive disorder.

Wang W, Liu J, Sun Y, Liu X, Ma Y, Gao X World J Psychiatry. 2024; 14(10):1484-1494.

PMID: 39474382 PMC: 11514565. DOI: 10.5498/wjp.v14.i10.1484.


Unveiling the interoception impairment in various major depressive disorder stages.

Zhou H, Liu J, Wu Y, Huang Z, Wang W, Ma Y CNS Neurosci Ther. 2024; 30(8):e14923.

PMID: 39154365 PMC: 11330652. DOI: 10.1111/cns.14923.


Brain-heart interaction disruption in major depressive disorder: disturbed rhythm modulation of the cardiac cycle on brain transient theta bursts.

Zhou H, Xiong T, Dai Z, Zou H, Wang X, Tang H Eur Arch Psychiatry Clin Neurosci. 2023; 274(3):595-607.

PMID: 37318589 DOI: 10.1007/s00406-023-01628-4.

References
1.
Mertens L, Wall M, Roseman L, Demetriou L, Nutt D, Carhart-Harris R . Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. J Psychopharmacol. 2020; 34(2):167-180. DOI: 10.1177/0269881119895520. View

2.
Williams I, Reuber M, Levita L . Interoception and stress in patients with Functional Neurological Symptom Disorder. Cogn Neuropsychiatry. 2020; 26(2):75-94. DOI: 10.1080/13546805.2020.1865895. View

3.
Ito Y, Shibata M, Tanaka Y, Terasawa Y, Umeda S . Affective and temporal orientation of thoughts: Electrophysiological evidence. Brain Res. 2019; 1719:148-156. DOI: 10.1016/j.brainres.2019.05.041. View

4.
Roiser J, Elliott R, Sahakian B . Cognitive mechanisms of treatment in depression. Neuropsychopharmacology. 2011; 37(1):117-36. PMC: 3238070. DOI: 10.1038/npp.2011.183. View

5.
Gorka S, Young C, Klumpp H, Kennedy A, Francis J, Ajilore O . Emotion-based brain mechanisms and predictors for SSRI and CBT treatment of anxiety and depression: a randomized trial. Neuropsychopharmacology. 2019; 44(9):1639-1648. PMC: 6785075. DOI: 10.1038/s41386-019-0407-7. View